Fate Therapeutics FATE
NASDAQ FATE
$2.30 -0.07 (-2.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Shares Outstanding (Diluted) (2020 - 2026)

Updated

Fate Therapeutics' Shares Outstanding (Diluted) was 120.4 million in Q2 2026, up 1.6% from 118.53 million a year earlier and up 0.3% from the prior quarter.

Analysis

Fate Therapeutics (FATE) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

For FY2025, Shares Outstanding (Diluted) at Fate Therapeutics came in at 118.79 million, up 4.5% from FY2024.

  • Shares Outstanding (Diluted) has now increased for five consecutive years, with a five-year compound annual growth rate of 7.6% (FY2020 to FY2025).
  • In earlier years, Shares Outstanding (Diluted) was 113.69 million in FY2024 (+15.5%), 98.41 million in FY2023 (+1.6%), 96.83 million in FY2022 (+2.2%) and 94.75 million in FY2021 (+15.0%).
  • The Q2 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2020.
  • Compared with a year earlier, Shares Outstanding (Diluted) has increased for 19 straight quarters, with growth averaging 7.7% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 0.9% in Q2 2025 to 19.5% in Q3 2024.
  • Per Business Quant data, FATE's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 120.03 million (Q1 2026), 118.79 million (Q4 2025) and 119 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.44 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.56 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 255.20 Mn
10 Fate Therapeutics 276.57 Mn 276.57 Mn - 120.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 120.40 Mn
Mar 31, 2026 120.03 Mn
Dec 31, 2025 118.79 Mn
Sep 30, 2025 119.00 Mn
Jun 30, 2025 118.53 Mn
Mar 31, 2025 118.38 Mn
Dec 31, 2024 113.69 Mn
Sep 30, 2024 117.77 Mn
Jun 30, 2024 117.47 Mn
Mar 31, 2024 101.10 Mn
Dec 31, 2023 98.41 Mn
Sep 30, 2023 98.57 Mn
Jun 30, 2023 98.40 Mn
Mar 31, 2023 98.05 Mn
Dec 31, 2022 96.83 Mn
Sep 30, 2022 97.02 Mn
Jun 30, 2022 96.70 Mn
Mar 31, 2022 96.34 Mn
Dec 31, 2021 94.75 Mn
Sep 30, 2021 95.41 Mn
API Access

Fate Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=FATE&period=max&api_key=YOUR_API_KEY